Literature DB >> 12821405

Secondary hyperalgesia and presynaptic inhibition: an update.

Fernando Cervero1, Jennifer M A Laird, Esther García-Nicas.   

Abstract

One of the most prominent features of secondary hyperalgesia is touch-evoked pain, i.e., pain evoked by dynamic tactile stimuli applied to areas adjacent or remote from the originating injury. It is generally accepted that the neurobiological mechanism of this sensory alteration involves the central nervous system (CNS) so that incoming impulses in low-threshold mechanoreceptors from the area of secondary hyperalgesia can evoke painful sensations instead of touch. Some years ago we proposed a mechanistic model for this form of pain based on presynaptic interactions in the spinal dorsal horn between the terminals of low-threshold mechanoreceptors and of nociceptors. Here we review the evidence gathered in support of this model in the intervening years with special reference to experimental studies of antidromic activity (Dorsal Root Reflexes--DRRs) in nociceptive afferents and on the acquisition of low-threshold inputs by nociceptor-specific neurons in the spinal dorsal horn. We also discuss and identify potential molecular mechanisms that may underlie the presynaptic interaction model and therefore that could be responsible for the development of secondary hyperalgesia.

Entities:  

Mesh:

Year:  2003        PMID: 12821405     DOI: 10.1016/s1090-3801(03)00047-8

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  37 in total

Review 1.  Kinase regulation of Na+-K+-2Cl- cotransport in primary afferent neurons.

Authors:  Eric Delpire; Thomas M Austin
Journal:  J Physiol       Date:  2010-05-24       Impact factor: 5.182

Review 2.  Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia.

Authors:  Theodore J Price; Fernando Cervero; Yves de Koninck
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

Review 3.  In search of lost presynaptic inhibition.

Authors:  Pablo Rudomin
Journal:  Exp Brain Res       Date:  2009-03-26       Impact factor: 1.972

4.  Nociception induces a differential presynaptic modulation of the synaptic efficacy of nociceptive and proprioceptive joint afferents.

Authors:  A Ramírez-Morales; E Hernández; P Rudomin
Journal:  Exp Brain Res       Date:  2021-06-08       Impact factor: 1.972

5.  Differential presynaptic control of the synaptic effectiveness of cutaneous afferents evidenced by effects produced by acute nerve section.

Authors:  P Rudomin; I Jiménez; D Chávez
Journal:  J Physiol       Date:  2013-03-11       Impact factor: 5.182

6.  Vasomotor response to cold stimulation in human capsaicin-induced hyperalgesic area.

Authors:  Dorit Pud; Ole Kaeseler Andersen; Lars Arendt-Nielsen; Elon Eisenberg; David Yarnitsky
Journal:  Exp Brain Res       Date:  2005-03-18       Impact factor: 1.972

Review 7.  Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

8.  Inflammation-induced shift in spinal GABA(A) signaling is associated with a tyrosine kinase-dependent increase in GABA(A) current density in nociceptive afferents.

Authors:  Yi Zhu; Shiv Dua; Michael S Gold
Journal:  J Neurophysiol       Date:  2012-08-22       Impact factor: 2.714

9.  Supraspinal modulation of neuronal synchronization by nociceptive stimulation induces an enduring reorganization of dorsal horn neuronal connectivity.

Authors:  E Contreras-Hernández; D Chávez; E Hernández; E Velázquez; P Reyes; J Béjar; M Martín; U Cortés; S Glusman; P Rudomin
Journal:  J Physiol       Date:  2018-03-26       Impact factor: 5.182

10.  Characterization of intrinsic properties of cingulate pyramidal neurons in adult mice after nerve injury.

Authors:  Xiao-Yan Cao; Hui Xu; Long-Jun Wu; Xiang-Yao Li; Tao Chen; Min Zhuo
Journal:  Mol Pain       Date:  2009-12-16       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.